Gregory M. Weinhoff, Chief Business Officer at Centessa Pharmaceuticals plc (CNTA), sold 60,000 shares at $12.17 ($734K) on 2024-08-22, disclosed to the SEC on 2024-08-23.
Scheduled sale ($734k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.17 | 12,198 | $148K | 20.2% |
| 2 | $12.17 | 12,198 | $148K | 20.2% |
| 3 | $12.29 | 17,802 | $219K | 29.8% |
| 4 | $12.29 | 17,802 | $219K | 29.8% |
| Total | $12.24 avg | 60,000 | $734K | 100% |
| Filing → |
| CNTA | SELL | 2025-07-25 | $156K | — | Filing → |
| CNTA | SELL | 2025-06-25 | $139K | — | Filing → |
| CNTA | SELL | 2025-05-27 | $128K | — | Filing → |